An IL-13 Inhibitor Blocks the Development of Hepatic Fibrosis During a T-Helper Type 2–dominated Inflammatory Response

Journal of Clinical Investigation - United States
doi 10.1172/jci7325
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation


Related search